Matsuda M, Petersson M, Lenkei R, Taupin J L, Magnusson I, Mellstedt H, Anderson P, Kiessling R
Microbiology and Tumor Biology Center (MTC), Karolinska Institute, Stockholm, Sweden.
Int J Cancer. 1995 Jun 9;61(6):765-72. doi: 10.1002/ijc.2910610605.
T cells from mice bearing an experimental colon carcinoma, and from patients with colorectal and renal carcinomas, have atypical T-cell receptors (TCR). In the present study, further characterization of modulations in CD3- and CD16-associated zeta chain in peripheral blood lymphocytes (PBL) and tumor-infiltrating lymphocytes (TIL) from colorectal carcinomas was performed. Relative to PBL, the percentage of natural killer (NK) cells among fresh TIL was reduced, while a higher proportion of T cells expressing HLA-DR was found. As previously reported, we found significantly reduced levels of the CD3- and CD16-associated zeta chain in TIL and, to a lesser extent, also in patients' PBL. Levels of zeta chain in T and NK cells from non-cancerous colorectal tissue from patients were lower than in PBL but higher than in TIL, with a direct relationship between levels of this signal-transducing molecule and the distance from the tumor. In addition, zeta levels correlated with the Dukes' stage of the disease, since PBL from patients with lymph-node involvement or distant organ metastases (Dukes' stages C and D) had significantly less CD3 zeta than patients with localized disease (stages A and B). Patients' T cells also had decreased levels of cell-surface and cytoplasmic CD3 epsilon. We also observed reduced levels of the TCR accessory molecules CD4 and CD8, mainly on TIL but to a lesser extent also on patients' PBL. Biochemical analysis of anti-CD3 epsilon-immunoprecipitated TCR complexes demonstrated that the CD3 complex was not associated with the zeta chain, either on TIL or on PBL or on lymphocytes from non-cancerous colon tissue, suggesting a defect in the assembly of the TCR complex. Following several days of in vitro culture with recombinant interleukin-2 and phytohemagglutinin, anti-CD3 or anti-CD2 monoclonal antibodies (MAbs), levels of CD3 zeta chain as well as of cell surface CD3 epsilon were normalized. Our findings suggest an abnormal expression as well as assembly of several different signal-transducing molecules of T cells and NK cells, which correlate with the stage of the disease in patients with colorectal carcinomas.
患有实验性结肠癌的小鼠以及患有结直肠癌和肾癌的患者的T细胞具有非典型T细胞受体(TCR)。在本研究中,对来自结直肠癌患者外周血淋巴细胞(PBL)和肿瘤浸润淋巴细胞(TIL)中与CD3和CD16相关的ζ链的调节进行了进一步表征。相对于PBL,新鲜TIL中自然杀伤(NK)细胞的百分比降低,而发现表达HLA-DR的T细胞比例更高。如先前报道,我们发现在TIL中与CD3和CD16相关的ζ链水平显著降低,在患者的PBL中也有一定程度的降低。来自患者非癌性结直肠组织的T细胞和NK细胞中的ζ链水平低于PBL,但高于TIL,并且该信号转导分子的水平与距肿瘤的距离呈直接关系。此外,ζ链水平与疾病的Dukes分期相关,因为有淋巴结受累或远处器官转移(Dukes分期C和D)的患者的PBL中CD3 ζ明显少于局限性疾病(分期A和B)的患者。患者的T细胞表面和细胞质CD3 ε水平也降低。我们还观察到TCR辅助分子CD4和CD8水平降低,主要在TIL中,但在患者的PBL中也有一定程度的降低。抗CD3 ε免疫沉淀的TCR复合物的生化分析表明,无论是在TIL、PBL还是非癌性结肠组织的淋巴细胞上,CD3复合物都不与ζ链相关,这表明TCR复合物的组装存在缺陷。在用重组白细胞介素-2和植物血凝素、抗CD3或抗CD2单克隆抗体(MAb)进行体外培养几天后,CD3 ζ链以及细胞表面CD3 ε的水平恢复正常。我们的研究结果表明,T细胞和NK细胞的几种不同信号转导分子存在异常表达和组装,这与结直肠癌患者的疾病分期相关。